BEDFORD, Mass.–(BUSINESS WIRE)–December 28, 2017–
Augmenix, Inc. a medical expertise firm that develops, manufactures, and sells proprietary absorbable hydrogels that separate and defend organs in danger throughout prostate radiotherapy, right now introduced that it will current on the 36th Annual J.P. Morgan Healthcare Conference on the Westin St. Francis Hotel in San Francisco on Tuesday, January 9, 2018. John Pedersen, President and Chief Executive Officer, is scheduled to current at 3:30 p.m. PST.
About Augmenix, Inc.
Augmenix, Inc. is a privately held firm primarily based within the Boston space centered on the event and commercialization of radiation oncology merchandise utilizing its proprietary hydrogel expertise. The firm was based by Incept LLC in 2008 and is funded by a number of main enterprise capital teams. More details about Augmenix could be discovered at http://www.Augmenix.com.
Eileen Gardner, RN, 781-902-1625
This article sources data from VentureBeat